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The Effect of Stage II Posterior Tibial Tendon Dysfunction on Deep
Compartment Muscle Strength: A New Strength Test
Jeff R. Houck, PhD, PT; Candace Nomides, MS, DPT; Christopher Glenn Neville, MS, PT; Adolph Samuel Flemister, MD
Rochester, NY

ABSTRACT

INTRODUCTION

Background: The purpose of this study was to compare
isometric subtalar inversion and forefoot adduction strength
in subjects with Stage II posterior tibial tendon dysfunction (PTTD) to controls. Materials and Methods: Twenty four
subjects with Stage II PTTD and fifteen matched controls
volunteered for this study. A force transducer (Model SML200, Interface, Scottsdale, AZ) was connected with a resistance plate and oscilloscope (TDS 410A, Tektronix, Beaverton,
OR) to the foot. Via the oscilloscope, subjects were given
feedback on the amount of force produced and muscle activation of the anterior tibialis (AT) muscle. Subjects were
instructed to maintain a plantar flexion force while performing
a maximal voluntary subtalar inversion and forefoot adduction
effort. A two-way ANOVA model with the factors including,
side (involved/uninvolved) and group (control/PTTD) was used.
Results: The PTTD group on the involved side showed significantly decreased subtalar inversion and foot adduction strength
(0.70 ± 0.24 N/Kg) compared to the uninvolved side (0.94 ±
0.24 N/Kg) and controls (involved side = 0.99 ± 0.24 N/Kg,
uninvolved side = 0.97 ± 0.21 N/Kg). The average AT activation
was between 11% to 17% for both groups, however, considerable variability in subjects with PTTD. Conclusion: These data
confirm a subtalar inversion and forefoot adduction strength
deficit by 20% to 30% in subjects with Stage II PTTD. Although
isolating the PT muscle is difficult, a test specific to subtalar
inversion and forefoot adduction demonstrated the weakness in
this population.

Posterior tibial tendon dysfunction (PTTD) is characterized by insidious onset of swelling and pain along the posterior tibial (PT) tendon that can lead to adult acquired flatfoot deformity.12 Subjects have progressed to Stage II when
signs of tendinopathy are coupled with a flexible flatfoot
deformity.12 Progressive loss of muscle function in Stage
II PTTD is suggested by abnormal gait patterns and difficulty with heel rise tasks, with little direct evidence of alterations in the muscle.4,21,30 Yet, new treatments for subjects
with Stage II PTTD are targeting the effects of exercise on
muscle/tendon recovery.4,16 Documenting muscle recovery
is beneficial when assessing the effects of these new treatments on the PT muscle.28 Yet, because all deep compartment muscles (flexor hallicus longus (FHL), flexor digitorum
longus (FDL) and PT) work synergistically to contribute
to subtalar inversion, it is not always clear which muscle
to attribute weakness to. Therefore, the challenge was to
design a test that is sensitive to PT muscle weakness to
mark the progression and/or recovery during the course of
PTTD.
A forefoot adduction strength test may be sensitive to PT
weakness due to muscle properties and joint mechanics. A
key measure of the ability of a muscle to produce force is
physiologic cross sectional area (PCSA).18 The PCSA takes
into account muscle anatomic cross sectional area and the
pennation angle of muscle fibers, providing a measure of
the muscle fibers in parallel. A review of in-vitro3,7,25,31
and in-vivo8 estimates of the PCSA of leg muscles suggests
the PCSA of the PT muscle is two to four times that of
the FDL and FHL (Table 1). In addition to muscle PCSA,
in-vitro studies suggest the moment arm of the PT muscle
is significantly larger than the FDL and FHL for subtalar
inversion.6,10,14 Unfortunately, the moment arms of the deep
compartment muscles at the talonavicualar joint and other
forefoot joints are not well understood.6 Flemister et al.
demonstrated that forefoot abduction/adduction movements
were associated with moment arm estimates of greater than
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Table 1: Comparison of Physiologic Cross Sectional Area (PCSA) (cm2 ) of deep compartment muscles from the literature
(Mean (%))
Study Results
Study 131
Muscle

PT
FHL
FDL
Total PCSA

20.8
5.3
5.1
31.2

(66.7)
(17.0)
(16.3)
(100)

Study 28
36.8
19.3
9.1
65.2

(56.4)
(29.6)
(14.0)
(100)

Study 37
22.6
13.7
6.1
42.4

(53.3)
(32.3)
(14.4)
(100)

Study 43
36.2
14.1
9.9
60.2

(60.1)
(23.4)
(16.5)
(100)

∗

Study 525

16.0
9.0
4.5
29.5

(54.2)
(30.5)
(15.3)
(100)

Mean %
(range)
58.1 (53.3 –66.7)
26.6 (17.0 –32.3)
15.3 (14.0 –16.5)
100

Posterior tibialis, PT; Flexor hallicus longus, FHL; Flexor digitorum longus, FDL.
∗ This data is from anatomic cross-sectional area which does not take into account pennation angle.

2 cm for the PT muscle, with muscle shortening occurring
during forefoot adduction.6 In support of the importance
of forefoot movement, an in-vivo study noted that subtalar
inversion and forefoot adduction tasks have greater task
specificity than 3 other tasks for isolating the PT muscle
from other leg muscles.15 Therefore, because of PCSA, joint
moment arms and task specificity, changes in PT muscle
function are expected to overshadow the synergistic roles
of the other deep compartment muscles when performing a
strength test with a subtalar inversion and forefoot adduction
task.
Another key element of strength testing of the PT muscle
is co-contraction of the anterior tibialis (AT) muscle. Ankle
plantarflexion is advocated to inhibit the synergistic contribution of the AT muscle when attempting to detect weakness.13
Ankle plantarflexion is thought to minimize the contribution
of the AT muscle on subtalar inversion and forefoot adduction either through task specificity or by placing the muscle
in a lengthened, and presumably mechanically disadvantaged
position.13 However, no studies were found that investigated
the AT muscle activation of subjects with PTTD during an
ankle plantarflexion, subtalar inversion and forefoot adduction strength test. Effectiveness of this clinical strategy to
detect PT muscle strength partly relies on the ability to minimize the contribution of the AT muscle, suggested by low
activation during maximal efforts.
The purpose of this study was to compare isometric
subtalar inversion and forefoot adduction strength in Stage
II PTTD subjects to controls. The subtalar inversion and
forefoot adduction task was hypothesized to be sensitive
to PT muscle weakness because of muscle properties, joint
mechanics and task specificity in subjects with Stage II
PTTD. Ankle plantarflexion was expected to minimize the
activation of the AT muscle. However, the potential for
subjects with PT muscle weakness to compensate with AT
activation was anticipated. A goal of nominal AT activation
of less than 10% was set a priori for both subjects with Stage
II PTTD and controls.

MATERIALS AND METHODS
Subjects

Twenty-four subjects with Stage II PTTD (18 females,
6 males) and 15 controls (12 females, 3 male) volunteered
after giving informed consent. The subjects with PTTD were
representative of the population, who frequently are middle
aged or older, female, and overweight (Table 2). The control
subjects were matched for age and body mass index of
the first 10 PTTD subjects enrolled. The control subjects
were required to have no known foot pathology and be free
of lower extremity pain for the last 6 months. Inclusion
criteria for the PTTD group required signs of 1) tendon
pathology and 2) unilateral flexible flatfoot deformity. Signs
of tendon pathology included pain and/or swelling along the
medial ankle. Signs of flatfoot deformity were determined by
clinical assessment with any one of the following, 1) greater
unilateral hindfoot eversion, 2) greater forefoot abduction
and/or 3) lower medial longitudinal arch height. To verify
the subjects with Stage II PTTD on average had abnormal
foot posture, the arch index was used (Table 2).32 The arch
index is the height from the floor to the top of the foot
at 50% of foot length divided by truncated foot length.
Truncated foot length is defined as the distance between the
most posterior aspect of the heel to the center of the first
metatarsol phalangeal joint. The reliability and validity of this
method has been reported in a previous study.32 Exclusion
criteria included inability to walk greater than 15 meters or
a history of previous foot or ankle pathology. A statistical
power analysis suggested that sample sizes above 10 subjects
per group were required to achieve 80% power with an
expected effect size of 0.30 N/Kg and standard deviation
of ±0.25 N/Kg.
Instrumentation

To capture maximal isometric efforts, a force transducer
(Model SML-200, Interface, Scottsdale, AZ) was connected
in series with a resistance plate and oscilloscope (TDS

Table 2: Sample, foot posture and self-report scores (Mean±SD)

SAMPLE
Age (years)
Height (cm)
Mass (kg)
Body Mass Index
Gender
Side Involved
FOOT POSTURE
Arch Index

p
value

Control (n = 15)

PTTD (n = 24)

55 ± 8
166 ± 11
77 ± 10
28 ± 5
F = 13, M = 2

61 ± 10
168 ± 10
84 ± 17.
30 ± 5
F = 18, M = 6
L = 14, R = 10

NS
NS
NS
NS

0.35 ± 0.03

0.31 ± 0.03

<0.001

SELF REPORTED SCORES
Foot Function Index (%)∗
Pain
Disability
Activity Limitation
Short Musculoskeletal
Function Assessment (%)∗
Function
Mobility
Bothersome

17 ± 11
36 ± 19
37 ± 17
24 ± 14
19 ± 12
23 ± 19

Posterior Tibial Tendon Dysfunction, PTTD; Female, F; Male, M; Left, L; Right, R.
∗ Higher scores indicate worse function.
NS = not significant.

410A, Tektronix, Beaverton, OR). Calibration of the force
transducer with known weights suggested low errors (r2 =
0.997, root mean square error = ±1 N). The resistance plate
was mounted on ball bearing tracks to allow for movement
in the medial/lateral direction. Thus, force exerted against
the resistance plate was detected by the force transducer
and displayed on the oscilloscope. A small pad, covered in
moleskin, that fit the general shape of the medial forefoot was
used to distribute pressure over the skin, allowing subjects to
exert maximal efforts against the resistance plate with little
discomfort. To assist subjects in maintaining a consistent
ankle plantarflexion and leg position, an air stirrup brace
(Aircast, Inc.) was utilized (Figure 1). However, the air
stirrup brace was not rigidly fixed to the uprights, thus
requiring subjects to achieve proximal stabilization through
active muscle control. The role of the air stirrup brace was
to assist the subject maintain a constant ankle plantarflexion
angle and foot posture. Inability to invert the hindfoot or raise
the medial longitudinal arch of the foot invalidated the test.
The air stirrup brace was set so the heel was approximately
10 cm above the resistance plate, resulting in varying degrees
of plantarflexion from 30 degrees to 45 degrees, depending
on foot size. Because the ankle plantarflexion angle has
little influence on PT muscle length, the influence of ankle

plantarflexion on isometric strength was assumed to be
negligible.6,14,20
Visual feedback of the amount of force exerted and muscle
activity of the AT muscle for each effort was provided via
an oscilloscope. After cleaning and abrading the skin, a
surface electrode (DE-2.1, Delsys, Inc., Boston, MA) was
placed in a standardized location (one hand width distal
to the tibial tuberosity) over the skin of the AT muscle.
The surface electrode was connected to a 2-channel EMG
system (Bangoli-2 EMG System, Delsys, Inc., Boston, MA)
and the gain was adjusted from 1 to 1000. The force
and muscle activity were displayed on the oscilloscope to
provide feedback to the examiner and subjects (Figure 1).
Readings were taken directly from the oscilloscope which
has a digital display that samples data at 1000 Hz. Peak
to peak EMG amplitudes in volts were recorded for the
maximum voluntary contraction (MVC) and strength testing
trials (Figure 1).
Procedure

The procedures included determining 10% AT activation
and peak isometric subtalar inversion and forefoot adduction.
Prior to performing a maximum inversion and forefoot
adduction effort, three maximal ankle dorsiflexion efforts
were recorded using manual resistance. As a benchmark,

EMG Eelectrode

A
Stirrup attachment

Adjustable Resistance Plate
1st Metatarsal head

Force transducer

B
Oscilloscope

EMG
Electrode

to maintain a plantarflexion moment while performing a
subtalar inversion and forefoot adduction effort. Subjects
were required to maintain neutral foot posture throughout the
test. Visually this meant maintenance of the medial longitunal
arch as judged by the examiner. This eliminated efforts that
involved simply dragging the foot across the foot plate with
proximal musculature. During the submaximal efforts, if AT
muscle activity was high (exceeded 10% of MVC), subjects
were coached to plantarflex more, and/or push medially with
their forefoot, diminishing the contribution of the AT muscle.
These commands were individualized to each subject, with
the goal of minimizing AT activation. Once the practice trials
were completed, visual feedback of the force and verbal
encouragement were used to motivate subjects to exert a
maximal effort. Peak force and peak to peak EMG amplitude
for each maximum subtalar inversion and foot adduction
effort was read from the oscilloscope and manually recorded.
For all subjects the sequence of which side was tested was
randomized.
Between session reliability

Eleven subjects from the control group volunteered to
perform the test again on a separate day. The second session
occurred less than a week from the first session. This interval
of time was sufficiently short to expect the same isometric
strength measures for both sessions. All the procedures above
were followed during each session. To minimize the chance
for examiner bias, the examiner was not allowed to review
the results of session one prior to performing the second
session. One examiner tested all subjects.
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Fig. 1: A, Picture of foot position. B, Picture of subject setup in the
instrumentation system for isometric subtalar inversion and foot adduction
strength testing. C, Display of peak force (converted from volts) and
electromyography (EMG).

10% of the highest peak to peak EMG signal of three
MVC trials for the AT muscle was used as a target for
examiners and subjects during the trials. To perform the
ankle inversion and forefoot adduction effort, the subject’s
foot was placed in the ankle stirrup, the foot plate was
adjusted to align the metatarsal head with the medial malleoli,
which placed the subject in a neutral or slightly abducted
foot position (Figure 1). After being properly positioned,
subjects performed five practice submaximal efforts and five
maximal efforts. During each effort, subjects were instructed

Analysis of strength and EMG data

The first analysis addressed reliability, while the second
addressed the comparison of isometric strength between the
controls and PTTD subjects. To assess the reliability of
the subtalar inversion and foot adduction peak force, an
intraclass correlation statistic (model 3, 1) was applied to the
session one and session two data. For the first hypothesis, the
dependent variable was the peak isometric subtalar inversion
and foot adduction force of the 3 maximal efforts. All force
values were normalized to body mass. A two-way mixed
effects ANOVA model was used to test for differences
between groups (between groups factor = PTTD vs. control)
and sides (within groups factor = involved vs. uninvolved).
For the control subjects, the right side was considered the
involved side and the left the uninvolved side. Preliminary
analyses suggested no side to side differences in control
subjects justifying this approach. A significant interaction,
indicating lower peak isometric force of the involved side
of the PTTD subjects compared to the uninvolved side of
subjects with PTTD and controls (both sides) was consistent
with the main hypothesis. In the presence of an interaction,
pairwise comparisons were used to test for differences across
groups and sides. Additionally, to mirror clinical practice,
where weakness is commonly assessed by comparing to

the opposite side, the ratio of involved to uninvolved
peak isometric subtalar inversion and foot adduction force
normalized to mass was compared between the Stage II
PTTD subjects and controls using a Student’s t-test.
Second, to assess whether the average AT muscle activation during the peak isometric subtalar inversion and foot
adduction test varied, the dependent variable was the peak to
peak EMG activation normalized to MVC (% MVC). Similarly, a two-way mixed effects ANOVA was used to test for
differences between groups (between groups factor = PTTD
vs. control) and sides (within groups factor = involved vs.
uninvolved). A significant interaction, indicating higher %
MVC on the involved side of the PTTD subjects compared
to the uninvolved side of the PTTD subjects and controls
(both sides) would suggest compensation with the AT muscle.
In the absence of an interaction, a main effect for group,
with the PTTD group showing higher AT muscle activation
than the controls would indicate substitution not unique to
muscle weakness. For all analyses (two-way mixed effects
ANOVA’s and Student’s t-test), an alpha level of 0.05 was
used for significance.
RESULTS

The between session reliability of the normalized peak
isometric subtalar inversion and foot adduction test was high
(Table 3).
There was a significant interaction between group and
side (p = 0.003), that resulted from a lower peak isometric
force of the involved side of the PTTD group. Normalized
peak isometric subtalar inversion and foot adduction force
for the PTTD group was significantly lower (p = 0.001)
at 0.70 ± 0.24 N/kg compared to the uninvolved side at
0.99 ± 0.24 N/Kg. The involved side for the PTTD group
was also significantly lower (involved p < 0.001 and uninvolved p = 0.001) as compared to both sides of the control
group (Table 4). A post hoc analysis revealed a mild significant correlation (r = −0.55, p < 0.001) between age and
normalized peak isometric subtalar inversion and foot adduction force. Because the groups showed a small difference

in age of 5.5 years (Table 2), that was close to significant
(Table 2, p = 0.07), the analysis was repeated with age as
a covariate. With age entered as a covariate the significant
interaction remained (p = 0.012) and no pairwise comparisons were changed. The ratio of the involved to the uninvolved side was also statistically (p = 0.003) lower in the
PTTD group compared to the controls. Post hoc analysis
suggested that the ratio of the involved to the uninvolved
side was not related to age (r = −0.263, p = 0.10) so no
further analysis was pursued.
The EMG activation of the AT muscle did not demonstrate
a significant interaction (p = 0.314) or main effect for group
(p = 0.324) (Table 4). However, the high standard deviations
in the PTTD group compared to the control group caused us
to examine AT activation more closely. In the PTTD group
the percent of subjects with less than 10% MVC of the AT
muscle was 54% and 46% on the involved and uninvolved
sides respectively. Similar percentages were observed in the
control group with 60% of subjects on both sides achieving
less than 10% MVC of the AT muscle. The highest AT
muscle activation of the control group on either side was
27% MVC. In contrast, three subjects in the PTTD group
used an AT activation that was higher than 27% MVC on
both sides.
DISCUSSION

The findings of this study suggest an isometric subtalar
inversion and forefoot adduction weakness in subjects with
Stage II PTTD as compared to controls. The results of
this study show a subtalar inversion and forefoot adduction
strength deficit of 20% to 30% in subjects classified with
Stage II PTTD. While isolated testing of the PT muscle
is difficult, a specific test based on muscle properties
(Table 1), joint mechanics and task specificity was sensitive
to weakness of the PT muscle. However, co-activation
of the AT muscle was high despite targeting lower coactivation levels. It is assumed that pain intensity (which
was not assessed in this study) during the testing may

Table 3: Reliability of isometric strength tests of control subjects (n = 11)

Trial 1

Trial 2

Variable
Subtalar Inversion and Foot Adduction
Normalized Force (N/Kg)∗ 100
Right side
97 ± 24
99 ± 25
Left side
97 ± 23
98 ± 22
Ratio of left/right
104 ± 30
100 ± 22
CI = Confidence Interval. ICC = ?

ICC Value-model 3, 1
(95% CI)

0.87 (0.56 –0.96)
0.91 (0.71 –0.98)
0.76 (0.32 –0.93)

Table 4: Average (SD) values for subtalar inversion and foot adduction
isometric strength
Control
(n = 15)
Variable
Normalized Force (N/Kg)∗ 100
99 ± 24
Involved Side∗
Uninvolved Side∗∗
96 ± 21
Ratio of left/right side
106 ± 31
Anterior tibialis muscle
Normalized EMG (% MVC)
Involved Side∗
12.5 ± 9.5
Uninvolved Side∗∗
11.3 ± 8.5

PTTD
(n = 24)

p value#

70 ± 24
94 ± 24
77 ± 25

0.005$
NS$
0.008

14.7 ± 15.0
17.1 ± 13.7

NS
NS

#

p values are for pair wise comparisons between control and PTTD groups.
p values are the result of performing the analysis with age entered as a covariate.
∗ Right side for controls.
∗∗ Left side for controls.
NS = not significant.
EMG = electromyography.
MVC = Maximum voluntary contraction.
$

have also influenced maximum efforts. Subject positioning
and proximal stabilization may also influence the specific
strength test proposed. The reliability data (Table 3) suggest
consistency in control subjects; however, consistency in
subjects with PTTD needs to be tested to improve clinical
interpretation.
Four factors specific to muscle function including 1) PCSA,
2) moment arms, 3) muscle activation and 4) pain may
contribute to the subtalar inversion and forefoot adduction
test being sensitive to PT weakness in subjects with PTTD.
The PCSA is a key morphologic measure of muscle that
reflects the ability of a muscle to produce force. Of the
deep compartment muscles (FDL, FHL and PT), the PT
muscle accounts for 60% of the PCSA (Table 1). A study
of subjects with PTTD just prior to surgery (an average
of 40 months of failed treatment) documented fatty infiltration in 3/12 PT muscles and deficits in muscle volume
of 2% to 17% compared to the uninvolved side.30 This
study supports the influence of PTTD on muscle volume,
and hence, PCSA. Also, in vitro studies document moment
arms in cadaver subjects but not in subjects with PTTD or
foot pronation.6,10,14 Nikki et al. documented the failure of
the PT muscle to raise the foot to the same position after
inducing flatfoot.19 One explanation for this decreased effectiveness of the PT muscle is a change in moment arms at
either the subtalar or talonavicular joints. Studies of subjects
after immobilization suggest weakness is a combination of
activation failure and muscle atrophy.26 Some degree of activation failure may also exist in subjects with PTTD. Also,
pain during the isometric strength test may inhibit maximal

efforts, contributing to activation deficits. Collectively, these
studies suggest that the subtalar inversion and foot adduction
isometric strength deficit of 20% to 30% observed in subjects
with PTTD is due to a combination of PT muscle weakness
and/or pain. Using a subtalar inversion and foot adduction
isometric strength test may provide an early indication of PT
muscle weakness in subjects with PTTD.
The greater activation of the AT muscle by the PTTD
group on the involved side suggests difficulty isolating the
PT muscle during the task. The average AT activation was
not statistically different between the control and PTTD
groups. However, only 60% of the subjects in the control
group and 40% to 50% of the subjects in the PTTD group
achieved the target of less than 10% activation. The 3
subjects in the PTTD group with activation greater than 30%
MVC showed severe weakness (ratio involved/uninvolved
side ranged from 0.50 to 0.60), suggesting they may have
been attempting to substitute for a weak PT muscle. For
this analysis, AT activation was presumed to have the
potential to mask weakness of the PT muscle. However,
the amount of AT activation did not correlate to the deficit
in PT isometric strength (r = −0.31, p = 0.14). This lack
of correlation, and the observation that those with the
highest AT activation demonstrated significant weakness
(ratio involved/uninvolved side ranged from 0.50 to 0.60),
suggests AT activation may not mask weakness for this task.
Because EMG only indicates neural drive and not mechanical
effects, this is possible. For example, the AT muscle is
significantly lengthened in the test position decreasing its
ability to generate force. Also, the AT muscle may not have

a significant moment arm for forefoot adduction, neutralizing
the mechanical effect of its activation. For example, the AT
moment arm for rearfoot inversion has been estimated as
20% of the moment arm for the PT muscle.14 Nevertheless,
less AT activation would indicate a more isolated measure of
the PT muscle, which was not achieved across subjects with
PTTD in this study. Other strength tests that use a dorsiflexed
foot position, such as isokinetic testing, are speculated to
induce even higher AT activation.
Clinical significance

Recent studies are exploring the potential for exercise to
alter the course of PTTD. Alvarez et al. reported an observational study that demonstrated promising outcomes using
an aggressive exercise regimen in subjects with Stage I and
II PTTD.4 Others reported the design of a clinical trial that
is underway to distinguish the benefits of eccentric versus
concentric exercise for subjects with PTTD.16 These exercise programs partially base their approach on the outcomes
observed with active treatment of the Achilles tendon.1,2
However, unlike Achilles tendinopathy, PTTD has been associated with damage to major foot ligaments5,9 and abnormal
walking mechanics.11,22,23,27 Further, in-vitro studies suggest
that the effectiveness of the PT muscle in controlling foot
posture partially depends on the integrity of foot ligaments.19
Because of this dependence of the effectiveness of the PT
muscle on foot ligaments, restoring the strength of the PT
muscle may have positive but limited therapeutic benefits. To
assess the effect of exercise programs, such as those proposed
above, methods to quantify PT muscle recovery are needed.
This study presents one testing method that appears sensitive
to PT muscle weakness. However, future research is needed
to determine test properties such as a clinical meaningful
change and responsiveness to improve clinical interpretation.
Clinicians are also advised that isolating the PT muscle fully
from AT muscle activation is difficult, with a high percentage
of subjects exceeding 10% activation.
Limitations

The ability to truly isolate the PT muscle from other
synergistic muscles is difficult. The air stirrup brace may
have inhibited or enhanced the contribution of the PT
muscle. Siegler et al.24 showed in-vivo that angular stiffness
(degrees/Nm) increased markedly toward the end range of
subtalar inversion and less so in the midrange. Because the
task is isometric, the midrange stiffness is more relevant. The
increased midrange stiffness of the air stirrup brace, although
small, may have limited inversion motion, inhibiting the full
contribution of the subtalar inverters. On the other hand,
the air stirrup brace may have improved the positioning of
the hindfoot in subjects with PTTD, increasing the moment
arm of the PT muscle at the subtalar joint.15,19 Both invitro19 and in-vivo15 studies document greater contributions
of the PT muscle when foot position is toward neutral.
Future studies may consider comparisons across different

testing positions. For example, Valderrabano et al.28 used
a sidelying position when evaluating subjects with PTTD
post operatively. The sidelying position also may provide
greater proximal stabilization of the tibia. Further, without
a direct comparison, it is unclear if isokinetic strength
testing as used by Alvarez et al.4 is sufficient to capture PT
muscle weakness. Alternative positioning and stabilization
strategies may also assist with inhibiting the AT muscle.
Because the AT muscle is an invertor, subtalar eversion with
plantarflexion may further inhibit this muscle.
Other limitations relate to reliability testing, the sample
used and limb dominance. A key limitation is that the
reliability testing was only performed on control subjects.
Reliability and responsiveness testing of subjects with PTTD
is necessary to establish the utility of this test clinically. In
addition, the clinical meaningfulness of a strength deficit is
not clear. Future studies focusing on repeated measurements
of isometric strength over time are needed. Another issue is
the sample characteristics of the PTTD and control groups.
Stage II PTTD is inclusive of a wide spectrum of disease
severity.17 As new stages are defined, the PTTD group
sample characteristics in Table 2 will be important to consider
when comparing across studies. Also, the use of a matched
control group on three key variables including gender, BMI,
and age may influence the results, as demonstrated by
the correlation of age and isometric strength. The effect
of limb dominance was not assessed in this study. Some
studies suggest that lower extremity dominance may account
for some of the variance when comparing side to side.29
However, side-to-side differences due to dominance are
unlikely to fully explain the 20% to 30% differences between
the PTTD subjects and controls observed in this study.
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